ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HVO Hvivo Plc

27.75
0.50 (1.83%)
Last Updated: 14:49:29
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hvivo Plc LSE:HVO London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 1.83% 27.75 27.50 28.00 27.75 27.25 27.25 696,922 14:49:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 56.04M 16.12M 0.0237 11.65 185.4M

Open Orphan PLC Total Voting Rights (1839C)

06/02/2020 9:30am

UK Regulatory


Hvivo (LSE:HVO)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Hvivo Charts.

TIDMORPH

RNS Number : 1839C

Open Orphan PLC

06 February 2020

6 February 2020

Open Orphan plc

("Open Orphan", the "Company" or the "Group")

Total voting rights

In conformity with the FCA's Disclosure Guidance and Transparency Rules, following Admission of the Placing and Subscription Shares, the Company confirms that as at the time of this announcement, its issued share capital consists of 532,507,581 ordinary shares of 0.1 pence each ("Ordinary Shares"). All of the Ordinary Shares have equal voting rights and there are no Ordinary Shares held in treasury. This figure of 532,507,581 Ordinary Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

Capitalised terms in this announcement shall have the same meanings given to such terms in the Group's announcement at 7.00 a.m. on 31 January 2020.

For further enquiries, please contact:

Open Orphan plc

Cathal Friel, Executive Chairman +353 (0)1 644 0007

Trevor Phillips, Chief Executive Officer +44 (0)20 7347 5350

Arden Partners plc (Nominated Adviser and Joint Broker) +44 (0)20 7614 5900

John Llewellyn-Lloyd / Benjamin Cryer

Davy (Euronext Growth Adviser and Joint Broker) +353 (0)1 679 6363

Anthony Farrell

Camarco (Financial PR) +44 (0)20 3757 4980

Tom Huddart / Daniel Sherwen

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRFIFETFTIRIII

(END) Dow Jones Newswires

February 06, 2020 04:30 ET (09:30 GMT)

1 Year Hvivo Chart

1 Year Hvivo Chart

1 Month Hvivo Chart

1 Month Hvivo Chart

Your Recent History

Delayed Upgrade Clock